Application Nr Approved Date Route Status External Links
NDA016295 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Hydrea Is Indicated For The Treatment Of: • Resistant Chronic Myeloid Leukemia. • Locally Advanced Squamous Cell Carcinomas Of The Head And Neck (Excluding The Lip) In Combination With Chemoradiation. Hydrea Is An Antimetabolite Indicated For The Treatment Of: Resistant Chronic Myeloid Leukemia. (1) Locally Advanced Squamous Cell Carcinomas Of The Head And Neck, (Excluding Lip) In Combination With Concurrent Chemoradiation. (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Hydroxyurea HYDROXYUREA ZINC8034120

Comments